Cargando…
PET as a Translational Tool in Drug Development for Neuroscience Compounds
In central nervous system drug discovery programs, early development of new chemical entities (NCEs) requires a multidisciplinary strategy and a translational approach to obtain proof of distribution, proof of occupancy, and proof of function in specific brain circuits. Positron emission tomography...
Autores principales: | Varrone, Andrea, Bundgaard, Christoffer, Bang‐Andersen, Benny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305164/ https://www.ncbi.nlm.nih.gov/pubmed/35201613 http://dx.doi.org/10.1002/cpt.2548 |
Ejemplares similares
-
ImmunoPET Directed to the Brain: A New Tool for Preclinical and Clinical Neuroscience
por: de Lucas, Ángel García, et al.
Publicado: (2023) -
Characterization of [(11)C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brain
por: Yang, Kai-Chun, et al.
Publicado: (2016) -
Key Developments in Translational Neuroscience: an Update
por: Stoyanov, Drozdstoy St.
Publicado: (2017) -
Revolutions in Neuroscience: Tool Development
por: Bickle, John
Publicado: (2016) -
Guidelines to PET measurements of the target occupancy in the brain for drug development
por: Takano, Akihiro, et al.
Publicado: (2016)